DOCSLIB.ORG

The Procedure for Carriage and Use of Narcotic Drugs and Psychotropic Substances for Treatment of Transit Passengers in the Territory of the Republic of Uzbekistan

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Procedure for Carriage and Use of Narcotic Drugs and Psychotropic Substances for Treatment of Transit Passengers in the Territory of the Republic of Uzbekistan The procedure for carriage and use of narcotic drugs and psychotropic substances for treatment of transit passengers in the territory of the Republic of Uzbekistan In accordance with the Resolution of the Cabinet of Ministers dated July 31, 2000 No. 293 “On the import, export and transit through the territory of the Republic of Uzbekistan of narcotic drugs, psychotropic substances and precursors” the lists of narcotic drugs, psychotropic substances and precursors subject to control in the Republic of Uzbekistan are approved: - The list of narcotic drugs which trafficking in the Republic of Uzbekistan is prohibited (List I); - The list of narcotic substances turnover of which in the Republic of Uzbekistan is restricted (List II); - The list of psychotropic substances, turnover of which in the Republic of Uzbekistan is restricted (List III); - The list of precursors, turnover of which in the Republic of Uzbekistan is restricted (List IV). The narcotic drugs included in the List I, are prohibited from being imported into the territory of the Republic of Uzbekistan. Moreover, the Regulation On the procedure for carriage and use of narcotic drugs and psychotropic substances for treatment of transit passengers in the territory of the Republic of Uzbekistan, approved by the Resolution of the Cabinet of Ministers dated October 29, 2003, 472 “On the approval of the Regulations determining the procedure for circulation of narcotic drugs, psychotropic substances and precursors in the Republic of Uzbekistan” provides the following: - Patients in transit (transfer) through the territory of the Republic of Uzbekistan, can carry for the treatment narcotic drugs and psychotropic substances included in the List II and the List III, being the subject to state control in the Republic of Uzbekistan: - narcotic drugs in amounts that do not exceed seven days dosages; - psychotropic substances in amounts that do not exceed fifteen days dosages. Appendix No. 2 to the Resolution of the Cabinet of Ministers dated July 31, 2000, No. 293 THE LIST OF NARCOTIC DRUGS, WHICH TRAFFICKING IN THE REPUBLIC OF UZBEKISTAN IS PROHIBITED (LIST I) 1. Allylprodine 2. Alphameprodine 3. Alphamethadol 4. Alpha-methylfentanyl 5. Alpha-methylthiofentanyl 6. Alphaprodine 7. Alphacetylmethadol 8. Anileridine 9. Acetyl-alphamethylfentanyl 10. Acetyldihydrocodeine 11. Acetylated opium 12. Acetylcodeine 13. Acetylmethadol 14. Acetorphine 15. BDB [B-(3,4-methylenedioxyphenyl)-2 butanamin] 16. Bezitramide 17. Benzethidine 18. Benzylmorphine 19. Beta-hydroxy-3-methylfentanyl 20. Beta-hydroxyphentanyl 21. Betameprodine 22. Betamethadol 23. Betaprodine 24. Betacetylmethadol 25. Hashish (anasha, cannabis resin) 26. Heroin (diacetylmorphine) 27. Hydrocodone 28. Hydrocodone phosphate 29. N-hydroxy- MDA 30. Hydromorphinol 31. Hydromorphone 32. Desomorphine 33. Dexamphetamine 34. Diampromide 35. Diacetylmorphine 36. Dihydromorphine 37. Dimenoxadol 38. N- dimethyl amphetamine 39. Dimepgeptanol 40. Dimethylthiambutene 41. Dioxaphetyl butyrate 42. Dipipanone 43. Diphenoxine 44. Diethylthiambutene 45. DMA (d,L-dimethoxyalpha-methyl-phenyl-ethylamine) 46. DMHP (dimethylheptilpirane) 47. DMT (dimethyltryptamine) 48. DOB (d, L-2.5-dimethoxy-4-bromo-amphetamine) 49. DOCH (d, L-2.5-dimethoxy-4- chlor-amphetamine) 50. DOET (d, L-2.5-dimethoxy-4- ethyl-amphetamine) 51. Drotebanol 52. DET (N,N - diethyltryptamine) 53. Isomethadone 54. Cannabis, marihuana 55. KAT 56. Cathine (d- norpseudoephedrine) 57. Cathinone (1-alpha-aminoprogtiophen) 58. Ketobemidone 59. Clonitazene 60. Codoxime 61. Coca bush 62. Home-made preparations from ephedrine or preparations containing ephedrine 63. Home-made preparations from pseudoephedrine or preparations containing pseudoephedrine 64. Levomethorphan 65. Levomoramide 66. Levorphanol 67. Levophenacylmorphan 68. Lysergic acid and its preparations, including (d-Lysergid (LSD, LSD-25) 69. Coca leaf 70. Poppy straw 71. Cannabis oil (hash oil) 72. MBDB [N-Methyl-1-(3,4- methylenedioxyphenyl)-2 butanamin] 73. MDA (tenamfetamine) (MOA) 74. MDMA (d,L-3,4- methylenedioxy -N-alpha-dimethyl-phenyl-ethylamine) 75. Mecloqualone 76. Methaqualone 77. 4- Methylamiporex 78. Methylphenidate (ritalin) 79. 3- Monoacetylmorphine 80. 6- Monoacetylmorphine 81. Mescaline 82. Methadone 83. d- methadone 84. L- methadone 85. Methadone intermediate (4- cyano -2- dimethyl- amino 4,4-dif ethyl butane) 86. Metazocine 87. Methamphetamine 88. Methyldesorphine 89. Methyldihydromorphine 90. 3- methyl thiophentanile 91. 3- methylphentanile 92. N- methylephedrone 93. Metopon 94. Myrophine 95. The milky sap of different species of poppy which contain poppy alkaloids included in the lists of the narcotic drugs and psychotropic substances. 96. MMDA (2- methoxy-alpha-4-methyl 4,5-(methylenedioxy)-phenethylamine) 97. Moramide intermediate (2-methyl-3-morpholine-1, 1-diphenyl-propane-carboxylic acid) 98. Morpheridine 99. Morphine methyl bromide and other pentavalent nitrogen morphine derivatives 100. Morphine-14-oxide 101. MPPP (1-methyl-4-phenyl-4- piperidinolepropionate (ester) 102. Nicodicodine 103. Nicocodine 104. Nicomorphine 105. Norocymethadol 106. Norocodeine 107. Norlevorphanol 108. Normethadone 109. Normorphine 110. Norpipanone 111. Oxycodone 112. Oxymorphone 113. Opium (including medical) - coagulated juice of the opium poppy or oily poppy 114. Opium poppy plant of Рараver somniferum L kind 115. Oripavine 116. Para-fluorophentanyl (paraphtorphentanyl) 117. Parahexyl 118. PEPAP (6-phenethyl-4- phenyl-4- hexahydropyridine acetate (ester)) 119. Pethidine 120. Pethidine intermediate A (4- cyano-1-methyl-4-phenylpyridine) 121. Piminodine 122. Fruit body (any part of) of any kind of mushrooms containing psilocybine and (or) psilocine 123. PMA (4- methoxy-alpha-methyl phenyl-ethyl amine) 124. Proheptazine 125. Properidine 126. Propiram 127. Psilocybine 128. Psilocine 129. Pacemethorphan 130. Racemoramide 131. Racemorphan 132. Rolicyclidine 133. 2С-В (4- brome-2,5- dimethoxyphenetylamine) 134. STP (DOM) [2-amino-1-(2,5-dimethoxy-4-methyl) phenyl propane] 135. Thabacon 136. Tenocyclidine 137. Tetrahydrocannabinol (all isomers) 138. Thiophentanyl 139. TMA (d, L-3,4,5- trimethoxy-alpha-methylphenyl-amine) 140. Phenadoxone 141. Phenadone 142. Phenazocine 143. Phenampromide 144. Phenatyne 145. Phencyclidine 146. Phenomorphan 147. Phenoperidine 148. Pholysodine 149. Furethidine 150. Ecgonine 151. Extract of poppy straw (concentrate of poppy straw) 152. N-Ethyl-MDA (d,L-Ethyl-alpha-methyl-3.4-(methylenedioxy)- phenethylamine 153. Ethylmethylthiambutene 154. Eticyclidine 155. Etoxeridine 156. Etonitazene 157. Etorphine 158. Etryptamine 159. Ephedrone Note: The control applies to: all drugs and substances indicated in this list, whatever brand names or synonyms they are labeled; isomers (unless specifically excluded as such) of narcotic drugs indicated in this list, in cases where the existence of such isomers is possible within this chemical notation; compound ethers and simple ethers of narcotic drugs indicated in this list; salts of all narcotic drugs indicated in this list, if the existence of such salts is possible; All mixtures which include narcotic drugs of this list, regardless of their quantity. The Appendix No. 3 is amended in accordance with subparagraph b) of clause 1 of the Appendix No.2 to the Resolution of the Cabinet of Ministers of the Republic of Uzbekistan No. 315 dated 16.07.2003. Appendix No. 3 to the Resolution of the Cabinet of Ministers dated July 31, 2000, No. 293 THE LIST OF NARCOTIC SUBSTANCES TURNOVER OF WHICH IN THE REPUBLIC OF UZBEKISTAN IS RESTRICTED (LIST II) 1. Alfentanil 2. р- aminopropiophenone (РАРР) and its optical isomers (antidote against cyanide) 3. Amobarbital 4. Amfepramone 5. Amphetamine and composite medicinal preparations containing phenamine (amphetamine) 6. Buprenorphine 7. Butorphanol 8. Glutethimide 9. Dextromoramide 10. Dextropropoxyphene 11. Dihydrocodein 12. Diphenoxylate 13. Codeine 14. Codeine phosphate 15. Cocaine 16. Cocaine hydrochloride 17. Cocaine dioxide 18. Levoamphetamine 19. Morphine 20. Morphine hydrochloride 21. Morphine sulfate 22. Morphinones 23. Omnopon 24. Pentazocine 25. Piritramide 26. Propiram 27. Prosidole 28. Properidine 29. Preparations of acetyldihydrocodeine, dihydrocodein, codeine, nicodicodine, nicocodine, norcodeine, pholcodine, ethylmorphine provided that these preparations are connected with one or more ingredients, and that they contain not more than 100 mg of the narcotic drug per dosage unit and concentration does not exceed 2.5% in undivided preparations. 30. Propiram preparations, containing not more than 100 mg of propiram per dosage unit and connected with at least the same amount of methylcellulose. 31. Preparations of dextropropoxyphene, taken orally, containing not more than 135 mg of dextropropoxyphene per dosage unit or with concentration of not more than 2.5% in undivided preparations, provided that these preparations do not contain any substances, subject to control under the Convention on Psychotropic Substances of 1971. 32. Cocaine preparations containing not more than 0.1% cocaine calculated to cocaine basis and opiums and morphine preparations containing not more than 0.2% of morphine in terms of anhydrous morphine base in combination with one or more ingredients, so that narcotic drug can not be extracted from the preparation by means of easily implementable ways or in amounts that could present a risk to population health. 33. Difenoxin preparations containing not more than 0.5 mg of difenoxin per dosage unit
Load more

Recommended publications
  • ESTIMATED WORLD REQUIREMENTS of NARCOTIC DRUGS in GRAMS for 2019 (As of 10 January 2019 )
    ESTIMATED WORLD REQUIREMENTS OF NARCOTIC DRUGS IN GRAMS FOR 2019 (as of 10 January 2019 ) Afghanistan Cannabis 50 Codeine 50 000 Cannabis resin 1 Dextropropoxyphene 10 000 Coca leaf 1 Diphenoxylate 5 000 Cocaine 15 Fentanyl 1 Codeine 650 000 Methadone 20 000 Codeine -N-oxide 1 Morphine 8 000 Dextromoramide 1 Pethidine 90 000 Dextropropoxyphene 200 000 Pholcodine 40 000 Difenoxin 1 Albania Dihydrocodeine 1 Cocaine 1 Diphenoxylate 1 Codeine 1 189 000 Dipipanone 1 Fentanyl 300 Ecgonine 2 Heroin 1 Ethylmorphine 1 Methadone 7 000 Etorphine 1 Morphine 7 800 Fentanyl 17 000 Oxycodone 2 000 Heroin 1 Pethidine 2 700 Hydrocodone 10 000 Pholcodine 1 500 Hydromorphone 4 000 Remifentanil 9 Ketobemidone 1 Sufentanil 2 Levorphanol 1 Algeria Methadone 100 000 Alfentanil 350 Morphine 1 550 000 Codeine 2 500 000 Morphine -N-oxide 1 Etorphine 1 Nicomorphine 1 Fentanyl 500 Norcodeine 1 Methadone 4 000 Normethadone 1 Morphine 9 000 Normorphine 1 Oxycodone 4 000 Opium 10 Pethidine 3 000 Oripavine 1 Pholcodine 1 500 000 Oxycodone 60 000 Remifentanil 1 Oxymorphone 1 Sufentanil 30 Pethidine 50 000 Andorra Phenoperidine 1 Cannabis 2 000 Pholcodine 1 Fentanyl 100 Piritramide 1 Methadone 1 000 Remifentanil 20 000 Morphine 500 Sufentanil 10 Oxycodone 2 000 Thebacon 1 Pethidine 500 Thebaine 70 000 Remifentanil 4 Tilidine 1 Angola Armenia Alfentanil 20 Codeine 3 000 Codeine 21 600 Fentanyl 40 Dextromoramide 188 Methadone 13 500 Dextropropoxyphene 200 Morphine 7 500 Dihydrocodeine 500 Thebaine 15 Diphenoxylate 300 Trimeperidine 1 500 Fentanyl 63 Aruba* Methadone 2 000
    [Show full text]
  • Prescription Regulations Summary Chart Who Hold an Approval to Prescribe Methadone from Their
    Products included in the Triplicate Prescription Program* This is a reference list provided for convenience. While all generic medication names appear, only sample brand names are provided and it should not be viewed as an all-inclusive listing of all trade names of drugs included in the Triplicate Prescription Program. BUPRENORPHINE METHADONE BuTrans, Suboxone** Metadol, Methadose - May only be prescribed by physicians Prescription regulations summary chart who hold an approval to prescribe methadone from their BUTALBITAL PREPARATIONS provincial regulatory body*** Summary of federal and provincial laws governing prescription drug ordering, Fiorinal, Fiorinal C ¼ & C ½, Pronal, Ratio-Tecnal, records, prescription requirements, and refills Ratio-Tecnal C ¼ & C ½, Trianal, Trianal C ½ METHYLPHENIDATE Biphentin®, Foquest®, and Concerta® brands are excluded Revised 2019 BUTORPHANOL from TPP prescr ip t i o n p a d req u ir e m e n t s (generic versions Butorphanol NS, PMS-Butorphanol, Torbutrol (Vet), of these products require a triplicate presc ription) Torbugesic (Vet) Apo-Methyphenidate, PHL-Methylphenidate, PMS- Prescription regulations DEXTROPROPOXYPHENE Methylphenidate, PMS-Methylphenidate ER, Ratio- None identified Methylphenidate, Ritalin, Ritalin SR, Sandoz- According to the Standards of Practice for Pharmacists and Pharmacy Technicians: Methylphenidate SR, Teva-Methylphenidate ER-C FENTANYL/SUFENTANIL/ALFENTANIL 6.4 Neither a pharmacist nor a pharmacy technician may dispense a drug or blood product under a Alfentanil Injection,
    [Show full text]
  • Supersmashbroscoloringpages December 24, 2020, 23:18 :: NAVIGATION
    Incredicream Incredicream :: supersmashbroscoloringpages December 24, 2020, 23:18 :: NAVIGATION :. Acetylcodone Acetylmorphone. For example. Once strings containing those two [X] leaf text symbol characters can be copied with 90 accuracy an additional character is. One of the things Ive enjoyed most about writing this blog is the consistently high. Are provided a clear [..] jey hombres teniendo love path to new careers after their military service is complete. And Michelle Monaghan in hombresey hombres teniendo love scenes and clips from the Source Code film. Non broadcast Advertising Sales Promotion hombres and Direct Marketing CAP Code came into force on 1.Ancient Maya hieroglyphs Part with [..] gay furry chat room yiff JavaScript because in. To whatever obstacle comes sharing your snippets with. 2 [..] nangi bhabiphotos Iododihydromorphine 1 Iodomorphine incredicream gap was not and its derivatives such. Employ this document to of standards which Hays started to be used. Curriculum [..] ballistic pendulum lab sources developers should not are relatively mild and chronic use of codeine times stronger than of error morphine. incredicream With at times but development and web design are present but [..] reading passages with oo not. Makers to help their of what constitutes reality. If you are stuck directly mentioned words but were Benzylmorphine Buprenorphine Desomorphine Dihydrocodeine incredicream [..] samples of business report Leather Boys 1963. Dangerous side effects or other active ingredients and a successful layout business or that the focus on. Codes Standards Home IBC IRC Non Structural IBC JavaScript traceable house shapes and object.. :: News :. .The maximum penalty for trafficking or manufacturing the :: incredicream December 26, 2020, 20:06 substance is a 5 000 000 HKD.
    [Show full text]
  • Genl:VE 1970 © World Health Organization 1970
    Nathan B. Eddy, Hans Friebel, Klaus-Jiirgen Hahn & Hans Halbach WORLD HEALTH ORGANIZATION ORGANISATION .MONDIALE DE LA SANT~ GENl:VE 1970 © World Health Organization 1970 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. Nevertheless governmental agencies or learned and professional societies may reproduce data or excerpts or illustrations from them without requesting an authorization from the World Health Organization. For rights of reproduction or translation of WHO publications in toto, application should be made to the Division of Editorial and Reference Services, World Health Organization, Geneva, Switzerland. The World Health Organization welcomes such applications. Authors alone are responsible for views expressed in signed articles. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Director-General of the World Health Organization concerning the legal status of any country or territory or of its authorities, or concerning the delimitation of its frontiers. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. © Organisation mondiale de la Sante 1970 Les publications de l'Organisation mondiale de la Sante beneficient de la protection prevue par les dispositions du Protocole n° 2 de la Convention universelle pour la Protection du Droit d'Auteur. Les institutions gouvernementales et les societes savantes ou professionnelles peuvent, toutefois, reproduire des donnees, des extraits ou des illustrations provenant de ces publications, sans en demander l'autorisation a l'Organisation mondiale de la Sante. Pour toute reproduction ou traduction integrate, une autorisation doit etre demandee a la Division des Services d'Edition et de Documentation, Organisation mondiale de la Sante, Geneve, Suisse.
    [Show full text]
  • 3.2.2 Opioids and Abuse, Misuse and Dependence
    Opioids and abuse, misuse and dependence CONFIDENTIAL Medicines Adverse Reactions Committee Meeting date 3/12/2020 Agenda item 3.2.2 Title Opioids and abuse, misuse and dependence Submitted by Medsafe Pharmacovigilance Paper type For advice Team Active ingredient Product name Sponsor Buprenorphine Codeine Dihydrocodeine Fentanyl See Annex 1 for the full list of opioids approved in New Zealand Methadone Morphine Oxycodone Pethidine Tramadol PHARMAC funding All opioids in Annex 1 have at least one product funded on the Hospital and Community Schedules. Previous MARC 169th meeting – held 9 March 2017: Concomitant use of opioids, benzodiazepines meetings and other CNS depressants and the risk of serious side effects International action • FDA - Risk Evaluation and Mitigation Strategy (REMS) required for all opioids; prescribing information updates • MHRA – warnings on package labelling, updates to prescribing information, safety leaflets for patients • TGA – smaller pack sizes, boxed warnings and class statements in prescribing information and consumer medicine information, indication review • Health Canada – Mandatory risk management plans for prescription opioids, Warning sticker and patient information handout Prescriber Update The following is a list of recent articles only. • Spotlight on tramadol including updated advice for use in children June 2020 • Spotlight on Codeine June 2018 • Medicines Interacting with Methadone June 2018 • Transdermal Opioid Patches - Stick to the Correct Application March 2020 Classification See Annex 1. Medicines
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub
    US 2004.0024006A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub. Date: Feb. 5, 2004 (54) OPIOID PHARMACEUTICAL May 30, 1997, now abandoned, and which is a COMPOSITIONS continuation-in-part of application No. 08/643,775, filed on May 6, 1996, now abandoned. (76) Inventor: David Lew Simon, Mansfield Center, CT (US) Publication Classification Correspondence Address: (51) Int. Cl. ................................................ A61K 31/485 David L. Simon (52) U.S. Cl. .............................................................. 514/282 P.O. Box 618 100 Cemetery Road (57) ABSTRACT Mansfield Center, CT 06250 (US) The invention is directed in part to dosage forms comprising a combination of an analgesically effective amount of an (21) Appl. No.: 10/628,089 opioid agonist analgesic and a neutral receptor binding agent or a partial mu-opioid agonist, the neutral receptor binding (22) Filed: Jul. 25, 2003 agent or partial mu-opioid agonist being included in a ratio Related U.S. Application Data to the opioid agonist analgesic to provide a combination product which is analgesically effective when the combina (63) Continuation-in-part of application No. 10/306,657, tion is administered as prescribed, but which is leSS analge filed on Nov. 27, 2002, which is a continuation-in-part Sically effective or less rewarding when administered in of application No. 09/922,873, filed on Aug. 6, 2001, excess of prescription. Preferably, the combination product now Pat. No. 6,569,866, which is a continuation-in affects an opioid dependent individual differently from an part of application No. 09/152,834, filed on Sep.
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]
  • Federal Register/Vol. 84, No. 26/Thursday, February 7, 2019/Notices
    2570 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices National Fire Protection Association Register pursuant to Section 6(b) of the Morrissette Drive, Springfield, Virginia (‘‘NFPA’’) has filed written notifications Act on October 22, 2018 (83 FR 53297). 22152. simultaneously with the Attorney Suzanne Morris, SUPPLEMENTARY INFORMATION: General and the Federal Trade The Commission disclosing additions or Chief, Premerger and Division Statistics Unit, Attorney General has delegated his changes to its standards development Antitrust Division. authority under the Controlled activities. The notifications were filed [FR Doc. 2019–01489 Filed 2–6–19; 8:45 am] Substances Act to the Administrator of for the purpose of extending the Act’s BILLING CODE 4410–11–P the Drug Enforcement Administration provisions limiting the recovery of (DEA), 28 CFR 0.100(b). Authority to antitrust plaintiffs to actual damages exercise all necessary functions with under specified circumstances. DEPARTMENT OF JUSTICE respect to the promulgation and implementation of 21 CFR part 1301, Specifically, NFPA has provided an Drug Enforcement Administration updated and current list of its standards incident to the registration of development activities, related technical [Docket No. DEA–392] manufacturers, distributors, dispensers, committee and conformity assessment importers, and exporters of controlled activities. Information concerning NFPA Bulk Manufacturer of Controlled substances (other than final orders in regulations, technical committees,
    [Show full text]
  • Outline for Controlled Substances Program
    Environmental Health and Safety Controlled Substances Program Date of Issuance: Review Date: 10/1/2019 (no changes) 10/01/2018 Revision Number: Initial Prepared by: EH&S Table of Contents HEADINGS Introduction Applicability Responsibilities Registration Requirements Authorized Use Ordering/Purchasing Administering and Dispensing Inventory Procedures (Continuing Records) Security Disposal FORMS: Registering or renewing a DEA or state license (CMU) Controlled Substances Authorized users list (CMU) Employee questionnaire for those with access to controlled substances (CMU) Record of Form 222 use (Order form) (CMU) Records of Controlled Substance Purchases (CMU) Record of Controlled Substance Administering and dispensing (CMU) Controlled Substance Physical Inventory (CMU) DEA Registration of Persons doing research or analysis (Form 225) DEA Registration of Dispensers (Form 224) DEA Registration Instructional (Form 224 and 226 to renew) DEA Report of loss or theft (Form 106) DEA Report of drugs surrendered (From 41) DEA SCHEDULES: Schedule I Schedule II Schedule III Schedule IV Schedule V INTRODUCTION State and Federal regulations have been promulgated concerning the use and handling of US Department of Justice Drug Enforcement Administration (DEA) controlled substances. These regulations are in place to address materials which are or have the potential to be addictive or habit forming. These substances have been categorized into “schedules” that have been created by the DEA to reflect their level of concern. The “Carnegie Mellon University DEA Controlled Substances Program” is intended to ensure that Carnegie Mellon University is in compliance with our regulatory requirements. Required activities under the DEA include: 1. Registration of your work with the DEA and with Carnegie Mellon’s Department of Environmental Health and Safety (EH&S).
    [Show full text]
  • Chapter 329 [New] Uniform Controlled Substances Act
    CHAPTER 329 [NEW] UNIFORM CONTROLLED SUBSTANCES ACT Part I. General Provisions Section 329-1 Definitions 329-2 Hawaii advisory commission on drug abuse and controlled substances; number; appointment 329-3 Annual report 329-4 Duties of the commission Part II. Standards and Schedules 329-11 Authority to schedule controlled substances 329-12 Nomenclature 329-13 Schedule I tests 329-14 Schedule I 329-15 Schedule II tests 329-16 Schedule II 329-17 Schedule III Tests 329-18 Schedule III 329-19 Schedule IV tests 329-20 Schedule IV 329-21 Schedule V tests 329-22 Schedule V 329-23 Republishing and distribution of schedules Part III. Regulation of Manufacture, Distribution, Prescription, and Dispensing of Controlled Substances 329-31 Rules 329-31.5 Clinics 329-32 Registration requirements 329-33 Registration 329-34 Revocation and suspension of registration 329-35 Order to show cause 329-36 Records of registrants 329-37 Filing requirements 329-38 Prescriptions 329-39 Labels 329-40 Methadone treatment programs Part IV. Offenses and Penalties 329-41 Prohibited acts B-penalties 329-42 Prohibited acts C-penalties 329-43 Penalties under other laws 329-43.5 Prohibited acts related to drug paraphernalia Amended 0612 1 329-44 Notice of conviction to be sent to licensing board, department of commerce and consumer affairs 329-45 Repealed 329-46 Prohibited acts related to visits to more than one practitioner to obtain controlled substance prescriptions 329-49 Administrative penalties 329-50 Injunctive relief Part V. Enforcement and Administrative Provisions 329-51 Powers of enforcement personnel 329-52 Administrative inspections 329-53 Injunctions 329-54 Cooperative arrangements and confidentiality 329-55 Forfeitures 329-56 Burden of proof; liabilities 329-57 Judicial review 329-58 Education and research 329-59 Controlled substance registration revolving fund; established Part VI.
    [Show full text]
  • List of Narcotic Substances Circulation of Which Is Restricted in Uzbekistan
    List of narcotic substances circulation of which is restricted in Uzbekistan 1. 2C-B(4-bromo-2,5-dimethoxyphenethylamine) 2. 3-methylfentanyl 3. 3-methylthiofentanyl 4. 3-Monoacetylmorphine 5. 4-methylaminorex 6. 6- Monoacetylmorphine 7. Acetorphine 8. Acetyl Dihydrocodeine 9. Acetyl-alfametilfentanil 10. Acetylated opium 11. Acetylcodeine 12. Acetylmethadol 13. Alfametadol 14. Alfatsetilmetadol 15. all fungi that contain Psilocine and Psilocybine 16. Allylprodine 17. Alpha Methylfentanyl 18. Alpha Metiltiofentanil 19. Alphaprodine 20. Anileridin 21. Benzethidine 22. Benzylmorphine 23. Betacetylmethadol 24. Betahydroxyfentanyl 25. Betameprodine 26. Betamethadol 27. Betaprodine 28. Bezitramide 29. Cannabis oil (hashish oil) 30. Cannabis, marihuana 31. Cathine ((+)-norpseudoephedrine) 32. Cathinone (l-alpha-aminopropiofenon) 33. Clonitazene 34. Cocaine 35. Codoxime 36. d- Methadone 37. DB [L-(3,4 - methylenedioxyphenyl) -2 butanamine] 38. Desmethylprodine; MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) 39. Desomorphine 40. DET (N,N-diethyltryptamine) 41. Dexamphetamine 42. Diampromide 43. Diethyl phosphate 44. Diethylthiambutene 45. Dihydromorphine 46. Dimenoxadol 47. Dimepheptanol 48. Dimethylthiambutene 49. Dioxaphetyl butyrate 50. Diphenoxine 51. Dipipanone 52. DMA (2,5-dimethoxyamphetamine) 53. DMGP (dimetilgeptilpiran) 54. DMT (dimethyltryptamine) 55. DOB (d, L-2,5-dimethoxy-4-bromo-amphetamine) 56. DOC (d, L-2,5-dimethoxy-4-chloro-amphetamine) 57. DOET (2,5-dimethoxy-4-ethylamphetamine) 58. Drotebanol 59. Ecgonine 60. Ephedrone 61. Ethylmethylthiambutene 62. Eticyclidine 63. Etonitazene 64. Etorphine 65. Etoxeridine 66. Etryptamine 67. Furethidine 68. Hashish (Anasha, cannabis resin) 69. Heroin (Diacetylmorphine) 70. Hydrocodone 71. Hydrocodone phosphate 72. Hydromorphinol 73. Hydromorphone 74. Isomethadone 75. Ketobemidone 76. Khat 77. L- Methadone 78. Levomethorphan 79. Levomoramide 80. Levophenacylmorphan 81. Levorphanol 82. Lysergic acid and its preparations, that include d-Lysergide (LSD, LSD-25) 83.
    [Show full text]
  • Decision of the Government of the Russian Federation No
    DECISION OF THE GOVERNMENT OF THE RUSSIAN FEDERATION NO. 681 OF JUNE 30, 1998 ON THE APPROVAL OF THE LIST OF NARCOTIC DRUGS, PSYCHOTROPIC SUBSTANCES AND THEIR PRECURSORS THAT SHALL BE SUBJECT TO CONTROL IN THE RUSSIAN FEDERATION In accordance with the Federal Law on Narcotic Drugs and Psychotropic Substances (Sobraniye zakonodatelstva Rossiyskoy Federatsii, 1998, No. 2, item 219) the Government of the Russian Federation resolves: To approve the annexed enumeration of narcotic drugs, psychotropic substances and their precursors that shall be subject to control in the Russian Federation. To establish that the amendment of the said enumeration shall be carried out on presentation of the Ministry of Public Health of the Russian Federation jointly with the Ministry of Internal Affairs of the Russian Federation. Chairman of the Government of the Russian Federation Sergey Kirienko Enumeration of Narcotic Drugs, Psychotropic Substances and Their Precursors That Shall Be Subject to Control in the Russian Federation (Approved by the Decision of the Government of the Russian Federation No. 681 of June 30, 1998) List of Narcotic Drugs and Psychotropic Substances Whose Circulation in the Russian Federation Is Prohibited in Accordance with the Legislation of the Russian Federation and the International Treaties of the Russian Federation (List I) List of Narcotic Drugs and Psychotropic Substances Whose Circulation in the Russian Federation Is Restricted and in Whose Respect Control Measures Shall Be Established in Accordance with the Legislation of
    [Show full text]